|
Volumn 36, Issue 8, 2008, Pages 2488-
|
Surviving sepsis campaign guidelines 2008: Revisiting vasopressor recommendations
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
ARGIPRESSIN;
DOPAMINE;
HYPERTENSIVE AGENT;
NORADRENALIN;
VASOCONSTRICTOR AGENT;
ADD ON THERAPY;
ARTERIAL PRESSURE;
CARDIOVASCULAR FUNCTION;
CLINICAL PROTOCOL;
DISEASE SEVERITY;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG INFUSION;
DRUG MEGADOSE;
HEART ARREST;
HEART INDEX;
HEMODYNAMICS;
HUMAN;
HYPOTENSION;
INTENSIVE CARE UNIT;
LETTER;
MEAN ARTERIAL PRESSURE;
MORTALITY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REFRACTORY SHOCK;
RISK;
SEPSIS;
SEPTIC SHOCK;
SIDE EFFECT;
SURVIVAL;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
NOTE;
PATHOPHYSIOLOGY;
ARGININE VASOPRESSIN;
HUMANS;
HYPOTENSION;
SEPSIS;
VASOCONSTRICTOR AGENTS;
|
EID: 49949105013
PISSN: 00903493
EISSN: 15300293
Source Type: Journal
DOI: 10.1097/CCM.0b013e318177764d Document Type: Letter |
Times cited : (3)
|
References (10)
|